
Offering scalable &
multi-modal cGMP solutions

Cell & Gene Therapy

Advanced Therapeutics

Biologics

Biopharmaceuticals

Chemical Manufacturing
GeneSuites is a biomanufacturing developer specializing in purpose-built cGMP High-Performance Shell (HPS) and Suite Solutions. Each cGMP solution by GeneSuites offers supporting infrastructure built into the facility enabling life science companies to accelerate speed to market.
GeneSuites customers can install their process equipment and ramp up their facility prior to clinical manufacturing with the option to launch their commercial product all under one roof. With an expert cGMP team, GeneSuites executes cGMP strategies through real estate solutions across site selection, facility design, construction, leasing, and creative financing.
BROWN/GREENFIELD
FACILITY ACQUISITION
HIGH-PERFORMANCE SHELL (HPS)
GeneSuites Developed Model
TURNKEY / SUITE SOLUTION
BUILD-TO-SUIT
SALE LEASEBACK

High-Performance Shell (HPS)
Advanced cGMP Building Shell Design
Facility is designed and delivered with cGMP-specific infrastructure such as boilers, chillers, electrical and additional time-saving components, beyond the offering of a typical industry cold shell. HPS remains flexible enough to support customer-specific improvements while providing average time savings of 12-18 months.

Suite Solution
Turnkey Design
The GeneSuites suite solution offers immense speed-to-market advantages with built-out cleanrooms, warehouse, PD, lab and office/admin space starting from 40K SF. Thoughtfully designed to be modular, the suites are scalable and suitable for early-to-mid stages companies.
Projects




RALEIGH-DURHAM, NC
-
700K+ SF cGMP, PD, Lab and Office
-
338,000 SF Purpose-Built cGMP Shells Complete with an Additional 388,000 SF Build-to-Suit Expansion Opportunity
-
12MW Power Secured
-
Available for Lease or Sale
Developed in partnership with affiliates of Apollo Global Management

HOUSTON, TX
-
Sites up to 300 Acres Available
-
Ability to accommodate Small to Large Requirements including High-Performance Shell
-
Innovation Campus/HQ Opportunity
-
Power Secured to Support Biomanufacturing
-
Available for Lease or Sale
Dedicated cGMP Development Partners for McCord Development




Achieve Commercialization Quickly & With More Certainty
Learn more about the GeneSuites model through our Whitepaper developed in partnership with Fierce Pharma.

The GeneSuites Advantage
Expert
cGMP Team
Combining cGMP, financing, and real estate expertise to develop solutions that remove existing barriers for biomanufacturing
Modular & Standardized Design
Ability to accommodate multiple therapies, processes and technologies within the same facility with separate infrastructure
Accelerate
Speed to Market
Quicker time to market than internal Build options; Potentially faster start than Buy (Contract Manufacturing)
Maximize
IP & Quality Control
Maximize control of intellectual property, process, methodologies, and tech transfers
Lower Upfront Capital Outlay
Enables companies to focus investment on science and clinical execution in earlier phase of development
Leverage
Scalability
Can accommodate pre-clinical through commercial scale